The Covaxin shot developed by Bharat Biotech will be used in an emergency situation or as a backup, once the immunisation process against coronavirus begins in the country, All India Institute of Medical Sciences Director Dr Randeep Guleria told ANI on Sunday.
“In an emergency situation when there is a sudden increase in cases and we need to vaccinate, Bharat Biotech vaccine will be used,” he said. “It can also be used as a back-up when we’re not sure how efficacious the Serum Institute vaccine is going to be.”
He further said that Serum Institute of India’s Covishield jab will be used in the initial phase of the vaccination drive.
“They [Serum] already have five crore doses available and they will be able to give that in initial phase where we will vaccinate three crore people,” he said. “Gradually, we will build on it and by the time Bharat Biotech data will also be available.”
Guleria’s comment came after Congress leaders raised concerns over…
